Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

Reply: "Association Between Lung Cancer and Calcium Channel Blockers Use".

Rotshild V, Perlman A, Matok I.

Ann Pharmacother. 2019 Oct;53(10):1074. doi: 10.1177/1060028019853285. Epub 2019 May 29. No abstract available.

PMID:
31137953
2.

Calcium Channel Blocker Use and the Risk for Prostate Cancer: A Population-Based Nested Case-Control Study.

Rotshild V, Azoulay L, Feldhamer I, Perlman A, Muszkat M, Matok I.

Pharmacotherapy. 2019 Jun;39(6):690-696. doi: 10.1002/phar.2266. Epub 2019 Apr 17. Erratum in: Pharmacotherapy. 2019 Sep;39(9):964.

PMID:
30917404
3.

Appropriateness of direct oral anticoagulant dosing and its relation to drug levels in atrial fibrillation patients.

Hirsh Raccah B, Rottenstreich A, Zacks N, Matok I, Danenberg HD, Pollak A, Kalish Y.

J Thromb Thrombolysis. 2019 May;47(4):550-557. doi: 10.1007/s11239-019-01815-y.

PMID:
30689152
4.

Management strategies of the interaction between direct oral anticoagulant and drug-metabolizing enzyme inducers.

Perlman A, Hochberg-Klein S, Choshen Cohen L, Dagan G, Hirsh-Raccah B, Horwitz E, Aldouby-Bier G, Negev T, Matok I, Azoulay L, Kalish Y, Muszkat M.

J Thromb Thrombolysis. 2019 May;47(4):590-595. doi: 10.1007/s11239-018-01804-7.

PMID:
30617727
5.

Trial of labor after cesarean delivery in twin gestations: systematic review and meta-analysis.

Kabiri D, Masarwy R, Schachter-Safrai N, Masarwa R, Hirsh Raccah B, Ezra Y, Matok I.

Am J Obstet Gynecol. 2019 Apr;220(4):336-347. doi: 10.1016/j.ajog.2018.11.125. Epub 2018 Nov 19. Review.

PMID:
30465748
6.

Calcium Channel Blockers and the Risk for Lung Cancer: A Population-Based Nested Case-Control Study.

Rotshild V, Azoulay L, Feldhamer I, Perlman A, Glazer M, Muszkat M, Matok I.

Ann Pharmacother. 2019 May;53(5):445-452. doi: 10.1177/1060028018814684. Epub 2018 Nov 15.

PMID:
30442036
7.

Fluoroquinolones and Cardiovascular Risk: A Systematic Review, Meta-analysis and Network Meta-analysis.

Gorelik E, Masarwa R, Perlman A, Rotshild V, Abbasi M, Muszkat M, Matok I.

Drug Saf. 2019 Apr;42(4):529-538. doi: 10.1007/s40264-018-0751-2.

PMID:
30368737
8.

Drug interaction as a predictor of direct oral anticoagulant drug levels in atrial fibrillation patients.

Hirsh Raccah B, Rottenstreich A, Zacks N, Muszkat M, Matok I, Perlman A, Kalish Y.

J Thromb Thrombolysis. 2018 Nov;46(4):521-527. doi: 10.1007/s11239-018-1738-7.

PMID:
30196343
9.

FOUR AUTHORS REPLY.

Matok I, Masarwa R, Levine H, Perlman A.

Am J Epidemiol. 2018 Dec 1;187(12):2718. doi: 10.1093/aje/kwy203. No abstract available.

PMID:
30192910
10.

Prenatal exposure to selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors and risk for persistent pulmonary hypertension of the newborn: a systematic review, meta-analysis, and network meta-analysis.

Masarwa R, Bar-Oz B, Gorelik E, Reif S, Perlman A, Matok I.

Am J Obstet Gynecol. 2019 Jan;220(1):57.e1-57.e13. doi: 10.1016/j.ajog.2018.08.030. Epub 2018 Aug 28. Review.

PMID:
30170040
11.

CT Imaging of Enzymatic Activity in Cancer Using Covalent Probes Reveal a Size-Dependent Pattern.

Tsvirkun D, Ben-Nun Y, Merquiol E, Zlotver I, Meir K, Weiss-Sadan T, Matok I, Popovtzer R, Blum G.

J Am Chem Soc. 2018 Sep 26;140(38):12010-12020. doi: 10.1021/jacs.8b05817. Epub 2018 Sep 18.

12.

Cognition- and Dementia-Related Adverse Effects With Sacubitril-Valsartan: Analysis of the FDA Adverse Event Report System Database.

Perlman A, Hirsh Raccah B, Matok I, Muszkat M.

J Card Fail. 2018 Aug;24(8):533-536. doi: 10.1016/j.cardfail.2018.04.010. Epub 2018 May 7.

PMID:
29746915
13.

WITHDRAWN: Cognition and Dementia Related Adverse Effects with Sacubitril-Valsartan: Analysis of the FDA Adverse Event Report System Database.

Perlman A, Raccah BH, Matok I, Muszkat M.

J Card Fail. 2018 May 7. pii: S1071-9164(18)30169-6. doi: 10.1016/j.cardfail.2018.04.009. [Epub ahead of print]

PMID:
29746914
14.
15.

Gender Differences in Efficacy and Safety of Direct Oral Anticoagulants in Atrial Fibrillation: Systematic Review and Network Meta-analysis.

Raccah BH, Perlman A, Zwas DR, Hochberg-Klein S, Masarwa R, Muszkat M, Matok I.

Ann Pharmacother. 2018 Nov;52(11):1135-1142. doi: 10.1177/1060028018771264. Epub 2018 Apr 22.

PMID:
29681165
16.

Systematic Review, Meta-analysis, and Network Meta-analysis of the Cardiovascular Safety of Macrolides.

Gorelik E, Masarwa R, Perlman A, Rotshild V, Muszkat M, Matok I.

Antimicrob Agents Chemother. 2018 May 25;62(6). pii: e00438-18. doi: 10.1128/AAC.00438-18. Print 2018 Jun.

17.

Pregnancy Outcomes Following Exposure to Quinolone Antibiotics - a Systematic-Review and Meta-Analysis.

Ziv A, Masarwa R, Perlman A, Ziv D, Matok I.

Pharm Res. 2018 Mar 26;35(5):109. doi: 10.1007/s11095-018-2383-8.

PMID:
29582196
18.

The Risk for Lung Cancer Incidence with Calcium Channel Blockers: A Systematic Review and Meta-Analysis of Observational Studies.

Rotshild V, Azoulay L, Zarifeh M, Masarwa R, Hirsh-Raccah B, Perlman A, Muszkat M, Matok I.

Drug Saf. 2018 Jun;41(6):555-564. doi: 10.1007/s40264-018-0644-4. Review.

PMID:
29484611
19.

Acute renal failure with sodium-glucose-cotransporter-2 inhibitors: Analysis of the FDA adverse event report system database.

Perlman A, Heyman SN, Matok I, Stokar J, Muszkat M, Szalat A.

Nutr Metab Cardiovasc Dis. 2017 Dec;27(12):1108-1113. doi: 10.1016/j.numecd.2017.10.011. Epub 2017 Oct 18.

PMID:
29174031
20.

Z-drugs and risk for falls and fractures in older adults-a systematic review and meta-analysis.

Treves N, Perlman A, Kolenberg Geron L, Asaly A, Matok I.

Age Ageing. 2018 Mar 1;47(2):201-208. doi: 10.1093/ageing/afx167.

PMID:
29077902
21.

Prescriber response to computerized drug alerts for electronic prescriptions among hospitalized patients.

Zenziper Straichman Y, Kurnik D, Matok I, Halkin H, Markovits N, Ziv A, Shamiss A, Loebstein R.

Int J Med Inform. 2017 Nov;107:70-75. doi: 10.1016/j.ijmedinf.2017.08.008. Epub 2017 Aug 31.

PMID:
29029694
22.

The Fetal Safety of Enoxaparin Use During Pregnancy: A Population-Based Retrospective Cohort Study.

Shlomo M, Gorodischer R, Daniel S, Wiznitzer A, Matok I, Fishman B, Koren G, Levy A.

Drug Saf. 2017 Nov;40(11):1147-1155. doi: 10.1007/s40264-017-0573-7.

PMID:
28733971
23.
24.

Demonstration of early efficacy results of the delayed-release combination of doxylamine-pyridoxine for the treatment of nausea and vomiting of pregnancy.

Koren G, Clark S, Hankins GD, Caritis SN, Umans JG, Miodovnik M, Mattison DR, Matok I.

BMC Pregnancy Childbirth. 2016 Nov 24;16(1):371.

25.

Association of Acetaminophen and Ibuprofen Use With Wheezing in Children With Acute Febrile Illness.

Matok I, Elizur A, Perlman A, Ganor S, Levine H, Kozer E.

Ann Pharmacother. 2017 Mar;51(3):239-244. doi: 10.1177/1060028016678006. Epub 2016 Oct 28.

PMID:
27794128
26.

Major Bleeding and Hemorrhagic Stroke With Direct Oral Anticoagulants in Patients With Renal Failure: Systematic Review and Meta-Analysis of Randomized Trials.

Raccah BH, Perlman A, Danenberg HD, Pollak A, Muszkat M, Matok I.

Chest. 2016 Jun;149(6):1516-24. doi: 10.1016/j.chest.2015.12.029. Epub 2016 Jan 18. Review.

PMID:
26836922
27.

Antihypertensive and Statin Medication Use and Motor Function in Community-Dwelling Older Adults.

Perlman A, Shah RC, Bennett DA, Buchman AS, Matok I.

J Am Med Dir Assoc. 2016 Mar 1;17(3):220-4. doi: 10.1016/j.jamda.2015.10.007. Epub 2015 Nov 17.

28.

Maternal safety of the delayed-release doxylamine and pyridoxine combination for nausea and vomiting of pregnancy; a randomized placebo controlled trial.

Koren G, Clark S, Hankins GD, Caritis SN, Umans JG, Miodovnik M, Mattison DR, Matok I.

BMC Pregnancy Childbirth. 2015 Mar 18;15:59. doi: 10.1186/s12884-015-0488-1.

29.

The use of antidepressants and the risk of chronic atrial fibrillation.

Lapi F, Azoulay L, Kezouh A, Benisty J, Matok I, Mugelli A, Suissa S.

J Clin Pharmacol. 2015 Apr;55(4):423-30. doi: 10.1002/jcph.435. Epub 2015 Feb 4.

PMID:
25427727
30.

Studying the antiemetic effect of vitamin B6 for morning sickness: pyridoxine and pyridoxal are prodrugs.

Matok I, Clark S, Caritis S, Miodovnik M, Umans JG, Hankins G, Mattison DR, Koren G.

J Clin Pharmacol. 2014 Dec;54(12):1429-33. doi: 10.1002/jcph.369. Epub 2014 Aug 7.

PMID:
25052410
31.

Immortal time bias in observational studies of drug effects in pregnancy.

Matok I, Azoulay L, Yin H, Suissa S.

Birth Defects Res A Clin Mol Teratol. 2014 Sep;100(9):658-62. doi: 10.1002/bdra.23271. Epub 2014 Jul 1.

PMID:
24985740
32.

Neurotherapeutic effect of cord blood derived CD45+ hematopoietic cells in mice after traumatic brain injury.

Arien-Zakay H, Gincberg G, Nagler A, Cohen G, Liraz-Zaltsman S, Trembovler V, Alexandrovich AG, Matok I, Galski H, Elchalal U, Lelkes PI, Lazarovici P, Shohami E.

J Neurotrauma. 2014 Aug 15;31(16):1405-16. doi: 10.1089/neu.2013.3270. Epub 2014 Jul 14.

33.

Metoclopramide in pregnancy: no association with adverse fetal and neonatal outcomes.

Matok I, Perlman A.

Evid Based Med. 2014 Jun;19(3):115. doi: 10.1136/eb-2013-101654. Epub 2014 Jan 6. No abstract available.

PMID:
24393717
34.

Characteristics of women with nausea and vomiting of pregnancy who chose to continue compassionate use of placebo after a randomised trial.

Matok I, Umans J, Feghali MN, Clark S, Caritis S, Miodovnik M, Hankins G, Mattison DR, Nordeng H, Koren G.

J Obstet Gynaecol. 2013 Aug;33(6):557-60. doi: 10.3109/01443615.2013.774327.

PMID:
23919849
35.

Exposure to nitrofurantoin during the first trimester of pregnancy and the risk for major malformations.

Goldberg O, Koren G, Landau D, Lunenfeld E, Matok I, Levy A.

J Clin Pharmacol. 2013 Sep;53(9):991-5. doi: 10.1002/jcph.139. Epub 2013 Jul 20.

PMID:
23873250
36.

Putative association of ABCB1 2677G>T/A with oxycodone-induced central nervous system depression in breastfeeding mothers.

Lam J, Kelly L, Matok I, Ross CJ, Carleton BC, Hayden MR, Madadi P, Koren G.

Ther Drug Monit. 2013 Aug;35(4):466-72. doi: 10.1097/FTD.0b013e318288f158.

PMID:
23783165
37.

Fetal safety of macrolides.

Bahat Dinur A, Koren G, Matok I, Wiznitzer A, Uziel E, Gorodischer R, Levy A.

Antimicrob Agents Chemother. 2013 Jul;57(7):3307-11. doi: 10.1128/AAC.01691-12. Epub 2013 May 6.

38.

Comparing the pharmacokinetics of doxylamine/pyridoxine delayed-release combination in nonpregnant women of reproductive age and women in the first trimester of pregnancy.

Matok I, Clark S, Caritis S, Miodovnik M, Umans J, Hankins G, Koren G.

J Clin Pharmacol. 2013 Mar;53(3):334-8. doi: 10.1177/0091270012445207. Epub 2013 Jan 24.

PMID:
23444286
39.

Hypertension and antihypertensive drugs in pregnancy and perinatal outcomes.

Orbach H, Matok I, Gorodischer R, Sheiner E, Daniel S, Wiznitzer A, Koren G, Levy A.

Am J Obstet Gynecol. 2013 Apr;208(4):301.e1-6. doi: 10.1016/j.ajog.2012.11.011. Epub 2012 Nov 15.

PMID:
23159698
40.

Folate Intake, MTHFR Polymorphisms, and the Risk of Colorectal Cancer: A Systematic Review and Meta-Analysis.

Kennedy DA, Stern SJ, Matok I, Moretti ME, Sarkar M, Adams-Webber T, Koren G.

J Cancer Epidemiol. 2012;2012:952508. doi: 10.1155/2012/952508. Epub 2012 Oct 18.

41.

Major malformations following exposure to nonsteroidal antiinflammatory drugs during the first trimester of pregnancy.

Daniel S, Matok I, Gorodischer R, Koren G, Uziel E, Wiznitzer A, Levy A.

J Rheumatol. 2012 Nov;39(11):2163-9. doi: 10.3899/jrheum.120453. Epub 2012 Sep 15.

PMID:
22984274
42.

Determinants of adherence to delayed-release doxylamine and pyridoxine in patients with nausea and vomiting of pregnancy.

Costantine MM, Matok I, Chiossi G, Clark S, Miodovnik M, Umans JG, Caritis S, Hankins GD, Koren G.

Ther Drug Monit. 2012 Oct;34(5):569-73.

43.

Dosage requirements for periconceptional folic acid supplementation: accounting for BMI and lean body weight.

Stern SJ, Matok I, Kapur B, Koren G.

J Obstet Gynaecol Can. 2012 Apr;34(4):374-8.

PMID:
22472339
44.

A systematic review of the fetal safety of interferon alpha.

Yazdani Brojeni P, Matok I, Garcia Bournissen F, Koren G.

Reprod Toxicol. 2012 Jun;33(3):265-8. doi: 10.1016/j.reprotox.2011.11.003. Epub 2011 Dec 19. Review.

PMID:
22200624
45.

Perception of teratogenic risk and the rated likelihood of pregnancy termination: association with maternal depression.

Walfisch A, Sermer C, Matok I, Einarson A, Koren G.

Can J Psychiatry. 2011 Dec;56(12):761-7.

PMID:
22152645
46.

The safety of fetal exposure to proton-pump inhibitors during pregnancy.

Matok I, Levy A, Wiznitzer A, Uziel E, Koren G, Gorodischer R.

Dig Dis Sci. 2012 Mar;57(3):699-705. doi: 10.1007/s10620-011-1940-3. Epub 2011 Oct 30.

PMID:
22038541
47.

Weight-depression association in a high-risk maternal population.

Walfisch A, Matok I, Sermer C, Koren G.

J Matern Fetal Neonatal Med. 2012 Jul;25(7):1017-20. doi: 10.3109/14767058.2011.614653. Epub 2011 Oct 4.

PMID:
21854131
48.

Screening for depressive symptoms.

Walfisch A, Sermer C, Matok I, Koren G, Einarson A.

Can Fam Physician. 2011 Jul;57(7):777-8. Review.

49.

CYP2D6 polymorphisms and codeine analgesia in postpartum pain management: a pilot study.

VanderVaart S, Berger H, Sistonen J, Madadi P, Matok I, Gijsen VM, de Wildt SN, Taddio A, Ross CJ, Carleton BC, Hayden MR, Koren G.

Ther Drug Monit. 2011 Aug;33(4):425-32. doi: 10.1097/FTD.0b013e3182272b10.

PMID:
21743374
50.

A comparison of folic acid pharmacokinetics in obese and nonobese women of childbearing age.

Stern SJ, Matok I, Kapur B, Koren G.

Ther Drug Monit. 2011 Jun;33(3):336-40. doi: 10.1097/FTD.0b013e318219407a.

PMID:
21572389

Supplemental Content

Support Center